-
1
-
-
61749087148
-
Emerging role of hepatocellular among liverrelated causes of deaths in HIV-infected patients: The French National Mortalité 2005 study
-
Salmon-Ceron D, Rosenthal E, Lewden C, Bouteloup V, May T, Burty C, et al. Emerging role of hepatocellular among liverrelated causes of deaths in HIV-infected patients: the French National Mortalité 2005 study. J Hepatol 2009; 50:736-745.
-
(2009)
J Hepatol
, vol.50
, pp. 736-745
-
-
Salmon-Ceron, D.1
Rosenthal, E.2
Lewden, C.3
Bouteloup, V.4
May, T.5
Burty, C.6
-
2
-
-
84871215063
-
Increasing incidence of hepatocellular carcinoma in HIV-infected patients in Spain
-
Merchante N, Merino E, López-Aldeguer J, Jover F, Delgado-Fernández M, Galindo MJ, et al. Increasing incidence of hepatocellular carcinoma in HIV-infected patients in Spain. Clin Infect Dis 2013; 56:143-150.
-
(2013)
Clin Infect Dis
, vol.56
, pp. 143-150
-
-
Merchante, N.1
Merino, E.2
López-Aldeguer, J.3
Jover, F.4
Delgado-Fernández, M.5
Galindo, M.J.6
-
3
-
-
84870700659
-
The risk of hepatocellular carcinoma among individuals with acquired immunodeficiency syndrome in the United States
-
Sahasrabuddhem VV, Shiels MS, McGlynn KA, Engels EA. The risk of hepatocellular carcinoma among individuals with acquired immunodeficiency syndrome in the United States. Cancer 2012; 118:6226-6233.
-
(2012)
Cancer
, vol.118
, pp. 6226-6233
-
-
Sahasrabuddhem, V.V.1
Shiels, M.S.2
McGlynn, K.A.3
Engels, E.A.4
-
4
-
-
84872144438
-
The prevalence of cirrhosis and hepatocellular carcinoma in patients with HIV infection
-
Ioannou GN, Bryson CL, Weiss NS, Miller R, Scott JD, Boyko EJ. The prevalence of cirrhosis and hepatocellular carcinoma in patients with HIV infection. Hepatology 2013; 57:249-257.
-
(2013)
Hepatology
, vol.57
, pp. 249-257
-
-
Ioannou, G.N.1
Bryson, C.L.2
Weiss, N.S.3
Miller, R.4
Scott, J.D.5
Boyko, E.J.6
-
5
-
-
33845669536
-
A sustained virological response to interferon or interferon/ribavirin reduces hepatocellular carcinoma and improves survival in chronic hepatitis C: A nationwide, multicentre study in Taiwan
-
Yu ML, Lin SM, Chuang WL, Dai CY, Wuang JH, Lu SN, et al. A sustained virological response to interferon or interferon/ribavirin reduces hepatocellular carcinoma and improves survival in chronic hepatitis C: a nationwide, multicentre study in Taiwan. Antivir Ther 2006; 11:985-994.
-
(2006)
Antivir Ther
, vol.11
, pp. 985-994
-
-
Yu, M.L.1
Lin, S.M.2
Chuang, W.L.3
Dai, C.Y.4
Wuang, J.H.5
Lu, S.N.6
-
6
-
-
19944428400
-
Antiviral therapy for cirrhotic hepatitis C: Association with reduced hepatocellular carcinoma development and improved survival
-
Shiratori Y, Ito Y, Yokosuka O, Imazeki F, Nakata R, Tanaka N, et al. Antiviral therapy for cirrhotic hepatitis C: association with reduced hepatocellular carcinoma development and improved survival. Ann Intern Med 2005; 142:105-114.
-
(2005)
Ann Intern Med
, vol.142
, pp. 105-114
-
-
Shiratori, Y.1
Ito, Y.2
Yokosuka, O.3
Imazeki, F.4
Nakata, R.5
Tanaka, N.6
-
7
-
-
77956635697
-
Outcome of sustained virological responders with histologically advanced chronic hepatitis C
-
Morgan TR, Ghany MG, Kim HY, Snow KK, Shiffman ML, de Santo JL, et al. Outcome of sustained virological responders with histologically advanced chronic hepatitis C. Hepatology 2010; 52:833-844.
-
(2010)
Hepatology
, vol.52
, pp. 833-844
-
-
Morgan, T.R.1
Ghany, M.G.2
Kim, H.Y.3
Snow, K.K.4
Shiffman, M.L.5
De Santo, J.L.6
-
8
-
-
0032996855
-
Interferon therapy lowers the rate of progression to hepatocellular carcinoma in chronic hepatitis C but not significantly in an advanced stage: A retrospective study in 1148 patients. Viral Hepatitis Therapy Study Group
-
Okanoue T, Itoh Y, Minami M, Sakamoto S, Yasui K, Sakamoto M, et al. Interferon therapy lowers the rate of progression to hepatocellular carcinoma in chronic hepatitis C but not significantly in an advanced stage: a retrospective study in 1148 patients. Viral Hepatitis Therapy Study Group. J Hepatol 1999; 30:653-659.
-
(1999)
J Hepatol
, vol.30
, pp. 653-659
-
-
Okanoue, T.1
Itoh, Y.2
Minami, M.3
Sakamoto, S.4
Yasui, K.5
Sakamoto, M.6
-
9
-
-
35648970573
-
Effect of sustained virological response on long-term clinical outcome in 113 patients with compensated hepatitis C-related cirrhosis treated by interferon alfa and ribavirin
-
Braks RE, Ganne-Carrie N, Fontaine H, Paries J, Grando-Lemaire V, Beaugrand M, et al. Effect of sustained virological response on long-term clinical outcome in 113 patients with compensated hepatitis C-related cirrhosis treated by interferon alfa and ribavirin. World J Gastroenterol 2007; 13: 5648-5653.
-
(2007)
World J Gastroenterol
, vol.13
, pp. 5648-5653
-
-
Braks, R.E.1
Ganne-Carrie, N.2
Fontaine, H.3
Paries, J.4
Grando-Lemaire, V.5
Beaugrand, M.6
-
10
-
-
75349096812
-
Antiviral therapy reduces risk of hepatocellular carcinoma in patients with hepatitis C virus-related cirrhosis
-
Singal AK, Singh A, Jaganmohan S, Guturu P, Mummadi R, Kuo YF, et al. Antiviral therapy reduces risk of hepatocellular carcinoma in patients with hepatitis C virus-related cirrhosis. Clin Gastroenterol Hepatol 2010; 8:192-199.
-
(2010)
Clin Gastroenterol Hepatol
, vol.8
, pp. 192-199
-
-
Singal, A.K.1
Singh, A.2
Jaganmohan, S.3
Guturu, P.4
Mummadi, R.5
Kuo, Y.F.6
-
11
-
-
33947360829
-
Sustained virological response to interferon-alpha is associated with improved outcome in HCV-related cirrhosis: A retrospective study
-
Bruno S, Stroffolini T, Colombo M, Bolani S, Benvegnù L, Mazzella G, et al. Sustained virological response to interferon-alpha is associated with improved outcome in HCV-related cirrhosis: a retrospective study. Hepatology 2007; 45:579-587.
-
(2007)
Hepatology
, vol.45
, pp. 579-587
-
-
Bruno, S.1
Stroffolini, T.2
Colombo, M.3
Bolani, S.4
Benvegnù, L.5
Mazzella, G.6
-
12
-
-
68949183159
-
Sustained virological response to interferon plus ribavirin reduces liver-related complications and mortality in patients coinfected with human immunodeficiency virus and hepatitis C virus
-
Berenguer J, Alvarez-Pellicer J, Mart?́n PM, López-Aldeguer J, von-Wichmann MA, Quereda C, et al. Sustained virological response to interferon plus ribavirin reduces liver-related complications and mortality in patients coinfected with human immunodeficiency virus and hepatitis C virus. Hepatology 2009; 50:407-413.
-
(2009)
Hepatology
, vol.50
, pp. 407-413
-
-
Berenguer, J.1
Alvarez-Pellicer, J.2
Mart́n, P.M.3
López-Aldeguer, J.4
Von-Wichmann, M.A.5
Quereda, C.6
-
13
-
-
84864129035
-
Relationship of liver disease stage and antiviral therapy with liver-related events and death in adults coinfected with HIV/HCV
-
Limketkai BN, Mehta SH, Sutcliffe CG, Higgins YM, Torbenson MS, Brinkley SC, et al. Relationship of liver disease stage and antiviral therapy with liver-related events and death in adults coinfected with HIV/HCV. JAMA 2012; 308:370-378.
-
(2012)
JAMA
, vol.308
, pp. 370-378
-
-
Limketkai, B.N.1
Mehta, S.H.2
Sutcliffe, C.G.3
Higgins, Y.M.4
Torbenson, M.S.5
Brinkley, S.C.6
-
14
-
-
28844480321
-
Management of hepatocellular carcinoma
-
Bruix J, Sherman M. Management of hepatocellular carcinoma. Hepatology 2005; 42:1208-1236.
-
(2005)
Hepatology
, vol.42
, pp. 1208-1236
-
-
Bruix, J.1
Sherman, M.2
-
15
-
-
79952231921
-
Management of hepatocellular carcinoma: An update
-
Bruix J, Sherman M. Management of hepatocellular carcinoma: an update. Hepatology 2011; 53:1020-1022.
-
(2011)
Hepatology
, vol.53
, pp. 1020-1022
-
-
Bruix, J.1
Sherman, M.2
-
16
-
-
34248592912
-
Care of patients coinfected with HIV and hepatitis C virus: 2007 updated recommendations from the HCV-HIV international panel
-
Soriano V, Puoti M, Sulkowski M, Cargnel A, Benhamou Y, Peters M, et al. Care of patients coinfected with HIV and hepatitis C virus: 2007 updated recommendations from the HCV-HIV international panel. AIDS 2007; 21:1073-1089.
-
(2007)
AIDS
, vol.21
, pp. 1073-1089
-
-
Soriano, V.1
Puoti, M.2
Sulkowski, M.3
Cargnel, A.4
Benhamou, Y.5
Peters, M.6
-
17
-
-
77957825574
-
Prediction of response to pegylated interferon plus ribavirin by IL28B gene variation in patients coinfected with HIV and hepatitis C virus
-
Pineda JA, Caruz A, Rivero A, Neukam K, Salas I, Camacho A, et al. Prediction of response to pegylated interferon plus ribavirin by IL28B gene variation in patients coinfected with HIV and hepatitis C virus. Clin Infect Dis 2010; 51:788-795.
-
(2010)
Clin Infect Dis
, vol.51
, pp. 788-795
-
-
Pineda, J.A.1
Caruz, A.2
Rivero, A.3
Neukam, K.4
Salas, I.5
Camacho, A.6
-
18
-
-
0345299824
-
Liver transplantation for the treatment of small hepatocellular carcinoma in patients with cirrhosis
-
Mazzaferro V, Regalia E, Doci R, Andreola S, Pulvirenti A, Bozzetti F, et al. Liver transplantation for the treatment of small hepatocellular carcinoma in patients with cirrhosis. N Engl J Med 1996; 334:693-699.
-
(1996)
N Engl J Med
, vol.334
, pp. 693-699
-
-
Mazzaferro, V.1
Regalia, E.2
Doci, R.3
Andreola, S.4
Pulvirenti, A.5
Bozzetti, F.6
-
19
-
-
0032879468
-
Prognosis of hepatocellular carcinoma: The BCLC staging classification
-
Llovet JM, Bru C, Bruix J. Prognosis of hepatocellular carcinoma: the BCLC staging classification. Semin Liver Dis 1999; 19:329-338.
-
(1999)
Semin Liver Dis
, vol.19
, pp. 329-338
-
-
Llovet, J.M.1
Bru, C.2
Bruix, J.3
-
20
-
-
84871487025
-
Association between sustained virological response and all-cause mortality among patients with chronic hepatitis C and advanced hepatic fibrosis
-
Van der Meer AJ, Veldt BJ, Feld JJ, Wedemeyer H, Dufour JF, Lammert F, et al. Association between sustained virological response and all-cause mortality among patients with chronic hepatitis C and advanced hepatic fibrosis. JAMA 2012; 308:2584-2593.
-
(2012)
JAMA
, vol.308
, pp. 2584-2593
-
-
Van Der Meer, A.J.1
Veldt, B.J.2
Feld, J.J.3
Wedemeyer, H.4
Dufour, J.F.5
Lammert, F.6
-
21
-
-
67349105629
-
Hepatitis C virus genotype 1b as a risk factor for hepatocellular carcinoma development: A meta-analysis
-
Raimondi S, Bruno S, Mondelli MU, Maisonneuve P. Hepatitis C virus genotype 1b as a risk factor for hepatocellular carcinoma development: a meta-analysis. J Hepatol 2009; 50:1142-1154.
-
(2009)
J Hepatol
, vol.50
, pp. 1142-1154
-
-
Raimondi, S.1
Bruno, S.2
Mondelli, M.U.3
Maisonneuve, P.4
-
22
-
-
80052825683
-
HCV genotype 3 is associated with a higher hepatocellular carcinoma incidence in patients with ongoing viral C cirrhosis
-
Nkontchou G, Ziol M, Aout M, Lhabadie M, Baazia Y, Mahmoudi A, et al. HCV genotype 3 is associated with a higher hepatocellular carcinoma incidence in patients with ongoing viral C cirrhosis. J Viral Hepat 2011; 18:e516-e522.
-
(2011)
J Viral Hepat
, vol.18
-
-
Nkontchou, G.1
Ziol, M.2
Aout, M.3
Lhabadie, M.4
Baazia, Y.5
Mahmoudi, A.6
-
23
-
-
79953173221
-
Boceprevir for untreated chronic HCV genotype 1 infection
-
Poordad F, McCone J, Bacon BR, Bruno S, Manns MP, Sulkowski MS, et al. Boceprevir for untreated chronic HCV genotype 1 infection. N Engl J Med 2011; 364:1195-1206.
-
(2011)
N Engl J Med
, vol.364
, pp. 1195-1206
-
-
Poordad, F.1
McCone, J.2
Bacon, B.R.3
Bruno, S.4
Manns, M.P.5
Sulkowski, M.S.6
-
24
-
-
79959438789
-
Telaprevir for previously untreated chronic hepatitis C virus infection
-
Jacobson IM, McHutchison JG, Dusheiko G, Di Bisceglie AM, Reddy KR, Bzowej NH, et al. Telaprevir for previously untreated chronic hepatitis C virus infection. N Engl J Med 2011; 364:2405-2416.
-
(2011)
N Engl J Med
, vol.364
, pp. 2405-2416
-
-
Jacobson, I.M.1
McHutchison, J.G.2
Dusheiko, G.3
Di Bisceglie, A.M.4
Reddy, K.R.5
Bzowej, N.H.6
-
25
-
-
84881409542
-
Telaprevir in combination with peginterferon alfa-2a/ribavirin in HCV/HIV co-infected patients: SVR24 final study results
-
9-13 November 2012; Boston, Massachusetts, USA. Abstract 54
-
Sulkowski MS, Sherman KE, Soriano V, Rockstroh J, Dieterich DT, Girard PM, et al. Telaprevir in combination with peginterferon alfa-2a/ribavirin in HCV/HIV co-infected patients: SVR24 final study results. Program and abstracts of the 63rd Annual Meeting of the American Association for the Study of Liver Diseases; 9-13 November 2012; Boston, Massachusetts, USA. Abstract 54.
-
Program and Abstracts of the 63rd Annual Meeting of the American Association for the Study of Liver Diseases
-
-
Sulkowski, M.S.1
Sherman, K.E.2
Soriano, V.3
Rockstroh, J.4
Dieterich, D.T.5
Girard, P.M.6
-
26
-
-
84871794419
-
Boceprevir plus pegylated interferon/ribavirin for the treatment of HCV/HIV co-infected patients
-
5-8 March 2011; Seattle, Washington, USA. Abstract 47
-
Sulkowski M, Pol S, Cooper C, Fainboim H, Slim J, Rivero A, et al. Boceprevir plus pegylated interferon/ribavirin for the treatment of HCV/HIV co-infected patients. 19th Conference on Retroviruses and Opportunistic Infections; 5-8 March 2011; Seattle, Washington, USA. Abstract 47.
-
19th Conference on Retroviruses and Opportunistic Infections
-
-
Sulkowski, M.1
Pol, S.2
Cooper, C.3
Fainboim, H.4
Slim, J.5
Rivero, A.6
-
27
-
-
84877262187
-
Safety and efficacy of telaprevir or boceprevir in combination with peginterferon alfa/ribavirin, in 497 cirrhotic non responders. Week 16 analysis of the French early access program (ANRS CO20-CUPIC) in real-life setting)
-
Boston, MA; 9-12 November 2012
-
Hezode C, Dorival C, Zoulim F, Larrey D, Pol S, Cacoub P, et al. Safety and efficacy of telaprevir or boceprevir in combination with peginterferon alfa/ribavirin, in 497 cirrhotic non responders. Week 16 analysis of the French early access program (ANRS CO20-CUPIC) in real-life setting). 63rd Annual Meeting of the American Association for the Study of Liver Diseases. Boston, MA; 9-12 November 2012.
-
63rd Annual Meeting of the American Association for the Study of Liver Diseases
-
-
Hezode, C.1
Dorival, C.2
Zoulim, F.3
Larrey, D.4
Pol, S.5
Cacoub, P.6
-
28
-
-
84892368388
-
Rapid virological response in HIV/HCVcoinfected patients with genotype 1 receiving telaprevir or boceprevir outside clinical trials: Results from HEPAVIRTHERAPY cohort
-
24-28 April 2013; Amsterdam, The Netherlands. Abstract 1860
-
Mira JA, Camacho A, López Cortés LF, Márquez M, Cifuentes C, Rivero-Juárez A, et al. Rapid virological response in HIV/HCVcoinfected patients with genotype 1 receiving telaprevir or boceprevir outside clinical trials: results from HEPAVIRTHERAPY cohort. 48th Annual Meeting of the European Association for the Study of the Liver; 24-28 April 2013; Amsterdam, The Netherlands. Abstract 1860.
-
48th Annual Meeting of the European Association for the Study of the Liver
-
-
Mira, J.A.1
Camacho, A.2
López Cortés, L.F.3
Márquez, M.4
Cifuentes, C.5
Rivero-Juárez, A.6
-
29
-
-
0037083159
-
Alcohol and hepatocellular carcinoma: The effect of lifetime intake and hepatitis virus infection in men and women
-
Donato F, Tagger A, Gelatti U, Parrinello G, Boffetta P, Albertini A, et al. Alcohol and hepatocellular carcinoma: the effect of lifetime intake and hepatitis virus infection in men and women. Am J Epidemiol 2002; 155:323-331.
-
(2002)
Am J Epidemiol
, vol.155
, pp. 323-331
-
-
Donato, F.1
Tagger, A.2
Gelatti, U.3
Parrinello, G.4
Boffetta, P.5
Albertini, A.6
|